https://www.selleckchem.com/pr....oducts/anacardic-aci
Existing evidence, research gaps, and perspectives of maternal-fetal particle transfer are highlighted. Multiple myeloma (MM) is a heterogeneous plasma cell malignancy that remains challenging to cure. Global hypomethylation correlates with an aggressive phenotype of the disease, while hypermethylation is observed at particular regions of myeloma such as B cell-specific enhancers. The recently discovered active epigenetic mark 5-hydroxymethylCytosine (5hmC) may also play a role in tumor biology; however, little is known about its
Like
Comment
Share
